Teva Pharmaceutical Industries Limited
$40.59B- Market cap
- $42.32B
- Debt
- +$1.82B
- Cash
- −$3.56B
Capital structure 96% equity / 4% debt · EV / Revenue 2.35x · EV / EBITDA 9.90x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
TEVA · current priceP/E 30.02x
$36.32Latest market snapshot
Implied fair value · at CTVA's multiple
$65.6780.8% above market
1.21 TEVA EPS (TTM)×54.27x CTVA P/E=$65.67
Market $36.32Implied $65.67
CTVA · current priceP/E 54.27x
$86.83Latest market snapshot
Implied fair value · at TEVA's multiple
$48.0344.7% below market
1.60 CTVA EPS (TTM)×30.02x TEVA P/E=$48.03
Market $86.83Implied $48.03